ArticleRadiological physics and technology2026
A radiology-aware fuzzy deep learning framework with entropy-guided feature selection for robust multi-disease chest X-ray classification across multiple magnifications.
Article in Radiological physics and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chest X-ray (CXR) imaging remains the most widely used and cost-effective modality for diagnosing thoracic diseases, yet automated multi-disease interpretation remains challenging due to acquisition variability, subtle overlapping pathologies, and multi-class classification complexity. Existing deep learning approaches often lack uncertainty modeling, interpretability, and robustness across heterogeneous image resolutions, limiting clinical adoption. We propose a fuzzy deep learning framework for multi-disease CXR classification, integrating: (i) radiology-aware augmentation to enhance generalization while preserving diagnostic fidelity; (ii) a grayscale-optimized ResNet-50 backbone with spatial-channel attention for improved feature extraction of subtle abnormalities; (iii) entropy-guided recursive feature elimination (RFE) achieving > 85% dimensionality reduction with minimal information loss; and (iv) a hybrid fuzzy-neural classifier with confidence-weighted defuzzification for explicit uncertainty estimation and reliable handling of borderline cases. The framework was evaluated on four public datasets-COVID-19 Radiography, Tuberculosis CXR, CXR Pneumonia, and CXR COVID-19 Pneumonia-across four magnification levels (×1, ×2, ×5, ×20). At ×20 magnification, accuracies reached 0.9593, 0.9859, 0.9831, and 0.9576, with F1-scores up to 0.9889 and recalls up to 0.9755. Even at ×1, performance remained high (accuracy 0.9401; F1-score 0.9564). Compared with the strongest baseline (CNN), the proposed model improved accuracy by 3.5-8.6%, recall by 2.3-6.7%, and F1-score by 3.8-10.4%. The fuzzy-neural integration stabilized borderline predictions, while confidence-weighted defuzzification reduced false positives. Collectively, radiology-aware augmentation, entropy-guided feature selection, and fuzzy-deep integration enable high accuracy, robustness across resolutions, and interpretable predictions, demonstrating the framework's potential for deployment in heterogeneous clinical and portable imaging environments.
Indexed as
Identifiers
42530795What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.